The HIV Modelling Consortium Steering Committee is comprised of representatives from the following institutions & departments: National Institutes of Health, The Global Fund to Fight AIDS, Tuberculosis and Malaria, The World Bank, UNAIDS, US Centre for Disease Control World Health Organization, US Department of State (PEPFAR), in addition to up to 5 other invited individuals who may be either consumers or producers of mathematical models for HIV/AIDS. Every Steering Committee member is asked to agree to a Terms of Reference that defines their roles and responsibilities in relation to the HIV Modelling Consortium.
Steering Committee members from the aforementioned key institutions are nominated by the Director or most senior member of the team of the relevant department in that institution. For the other nominated Steering Committee members from the wider modelling community, nominations are sought from the Chairman and the previous or current Steering Committee (dependent on when a new replacement is required) and the decision is secured by majority vote.
- Chair | Bill & Melinda Gates Foundation
- Professor of Microparisite Epidemiology | Imperial College London
Prof. Geoff Garnett works at the Bill and Melinda Gates Foundation on improving the effectiveness of HIV programs and their sustainability in the context of generalized HIV epidemics. Geoff Garnett is also Professor of Microparasite Epidemiology at Imperial College London. His main area of research is the epidemiology and control of sexually transmitted infections. The development and analysis of mathematical models of the transmission dynamics of STDs provides a framework to analyse...
- U.S. Centers for Disease Control and Prevention
John M Blandford, PhD is Principal Deputy Director of the Division of Global HIV/AIDS (DGHA) at the U.S. Centers for Disease Control and Prevention (CDC), a key implementing agency of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), which represents the largest commitment by any nation to combat a single disease globally. In his current position, Dr. Blandford oversees the management of CDC’s global HIV treatment, care and prevention programs and of its more than 2,...
- Chief of the Clinical Prevention Research Branch, Prevention Sciences Program
- Division of AIDS, NIAID, National Institutes of Health
Dr. David N. Burns is currently chief of the Clinical Prevention Research Branch, Prevention Sciences Program, Division of AIDS, NIAID, NIH.
Dr. Burns received his bachelor’s degree in bacteriology and immunology from the University of California, Berkeley, medical degree from New York University, and MPH from Columbia University. After teaching general internal medicine for brief periods at Columbia University-Presbyterian Hospital and UCLA, he completed his infectious...
- World Health Organization
Dr. Meg Doherty is the Coordinator of Treatment and Care in the Department of HIV/AIDS at the World Health Organization (WHO) in Geneva, Switzerland and has been in this role since September 2012. She provides overall technical and managerial support to treatment and care for adults, adolescents, children and pregnant women, as well as, the development of the new consolidated global antiretroviral treatment guidelines. Prior to joining WHO, Dr. Doherty was an assistant professor...
- Senior Adviser on HIV and AIDS, The Global Fund to Fight AIDS, TB and Malaria
- Chief, Data for Action Division | UNAIDS
Since 1999, Peter Ghys has worked in a number of positions at UNAIDS focusing on the analysis of the AIDS epidemic. He currently holds the post of Chief, Data for Action Division. The Division’s main tasks include the analysis of levels and trends in the AIDS epidemic, and the monitoring and reporting of progress in the global AIDS response.
From 1992 until 1999, he directed the Sexually Transmitted Diseases section of Project RETRO-CI in Côte d’Ivoire. Dr Ghys is a physician and...
- Senior Fellow | Center for Global Development
Mead Over is a senior fellow at the Center for Global Development researching economics of efficient, effective, and cost-effective health interventions in developing countries. Much of his work since 1987, first at the World Bank and now at the CGD, is on the economics of the AIDS epidemic. After work on the economic impact of the AIDS epidemic and on cost-effective interventions, he co-authored the Bank’s first comprehensive treatment of the economics of AIDS in the book, Confronting AIDS...
Dr. Nalinee Sangrujee is a development economist and has over 15 years of experience conducting international policy development and economics research. She started as an economist in CDC’s Global Immunization Division conducting economic research on polio and measles vaccination strategies. She joined the Division of Global HIV/AIDS in 2009. Prior to joining the Division of Global HIV/AIDS she worked at the Futures Group conducting economics and modeling research in HIV/AIDS, maternal...
- Office of the U.S. Global AIDS Coordinator, US State Department
- Vice President | Avenir Health
John Stover is Vice President and founder of Avenir Health and served as Avenir Health’s first president. Previously John was a Vice President at Futures Group in the Center for Economics and Modeling. He has over 30 years of experience in assessing population and health issues in developing countries and in providing technical assistance in policy analysis and awareness-raising through computer modeling.
John has worked on a variety...
- Global HIV/AIDS Program Director | The World Bank
David Wilson is the World Bank's Global AIDS Program Director and was previous the Bank's Lead HIV Specialist. His work on HIV/AIDS spans almost 25 years. During his career he has worked as a scientist and program manager in over 50 countries and published approximately 100 scientific papers.
His interests lie in HIV epidemiology, HIV prevention science and program evaluation. He has developed prevention programs that have been recognized as best practice by the...